DUBLIN, Ireland, Jan. 15, 2021 (GLOBE NEWSWIRE) —
JPMorgan ETFs (Ireland) ICAV
Notice of Index Change
Please note that effective 29 January 2021 the following Index Tracking Sub-Funds will change Index in order to retain the current index exit maturity rules and the Sub-Fund Supplements will be updated accordingly. There will be no change to how the Sub-Funds are managed in practice.
JPMorgan ETFs (Ireland) ICAV – BetaBuilders US Treasury Bond UCITS ETF
JPMorgan ETFs (Ireland) ICAV – BetaBuilders US Treasury Bond 1-3 yr UCITS ETF
JPMorgan ETFs (Ireland) ICAV – BetaBuilders UK Gilt 1-5 yr UCITS ETF
JPMorgan ETFs (Ireland) ICAV – BetaBuilders EUR Govt Bond UCITS ETF
JPMorgan ETFs (Ireland) ICAV – BetaBuilders EUR Govt Bond 1-3 yr UCITS ETF
To view the full details, please paste the following URL into the address bar of your browser.
Enquiries:
JPMorgan
Annabel Dow
annabel.s.dow@jpmorgan.com
+44 207 7428379
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…
CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…
Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…
- Combination of evorpacept plus rituximab and lenalidomide (R2) generated complete responses (CR) in 92%…
Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab…
― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at…